Vividion Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
April 30, 2019
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$82,000,000

Company Info
Organizations Involved
Celgene Corporation
Company Description
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Market
Therapeutics for oncology and inflammation
Location
San Diego, California, USA
Coinvestors
Alexandria Venture Investments, Altitude Life Science Ventures, ARCH Venture Partners, BVF Partners, Cardinal Partners, Casdin Capital, Celgene Corporation, Mirae Asset Venture Investment, Mubadala Ventures, Nextech Invest, Trinitas Capital, Versant Ventures

Links